Octreotide

Octra Solution for Injection 0.1 MG/ML

0.1 mg/ml injection, solutionSingaporeAuthorisedAuthorised 28 May 2026

In other countries

The same active substances on other registers, the same brand first.

SANDOSTATIN 100 micrograme/mlRomania · 0,1mg/ml · sol. inj./perf. · Novartis Pharma GMBHSame strength and form
Sandostatin®Serbia · 0.1mg/mL · rastvor za injekciju/infuziju · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same strength and form
Sandostatin®Serbia · 0.1mg/mL · rastvor za injekciju/infuziju · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same strength and form
Sandostatin®Serbia · 0.1mg/mL · rastvor za injekciju/infuziju · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same strength and form
Octreotide AcetateUnited States · 0.05MG BASE/ML, 0.1MG BASE/ML, 0.2MG BASE/ML … · injectable · Sun Pharm IndsSame strength and form
Octreotide Acetate (Preservative Free)United States · 0.05MG BASE/ML, 0.1MG BASE/ML, 0.5MG BASE/ML · injectable · Sagent Pharms INCSame strength and form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Octreotide

Octra Solution for Injection 0.1 MG/ML

0.1 mg/ml injection, solutionSingaporeAuthorisedAuthorised 28 May 2026

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

SandostatinUnited States · 0.05MG BASE/ML, 0.1MG BASE/ML, 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … · injectable · Novartis

OCTREOTIDA GP-PHARM 0,1 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGSpain · 100 µg · solución inyectable y para perfusión · Gp Pharm S.A.

OCTREOTIDA GP-PHARM 0,5 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGSpain · 500 µg · solución inyectable y para perfusión · Gp Pharm S.A.

OCTREOTIDA GP-PHARM 1 mg /5 ml (0,2 mg/ml) SOLUCION INYECTABLE Y PARA PERFUSION EFGSpain · 1 mg · solución inyectable y para perfusión · Gp Pharm S.A.

Oktreotid Teva 20 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjemCroatia · prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem · Teva B.V., Swensweg 5, Haarlem, Nizozemska

Oktreotid Teva 30 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjemCroatia · prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem · Teva B.V., Swensweg 5, Haarlem, Nizozemska

Sandostatin 0,1 mg/ml otopina za injekciju/infuzijuCroatia · otopina za injekciju/infuziju · Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska

Octreotide Bioindustria L.I.M.Italy · Concentrato per soluzione per infusione · Bioindustria Laboratorio Italiano Medicinali S.P.A.

Octreotide SunItaly · Soluzione iniettabile · Sun Pharmaceutical Industries (Europe) B.V.

Octreotide TevaItaly · Polvere e solvente per sospensione iniettabile a rilascio prolungato · Teva B.V.

Octreotide Bendalis 0,05 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Bendalis GmbH

Octreotide Bendalis 0,1 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Bendalis GmbH

Octreotide Bendalis 0,2 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Bendalis GmbH

Max HealthNew Zealand · Inj 500 mcg per ml, 1 ml ampoule

Max HealthNew Zealand · Inj 50 mcg per ml, 1 ml ampoule

Max HealthNew Zealand · Inj 100 mcg per ml, 1 ml ampoule

SANDOSTATIN LAR 10 mgRomania · 10mg · pulb. si solv. pt. susp. inj. · Novartis Pharma GMBH

SANDOSTATIN LAR 20 mgRomania · 20mg · pulb. si solv. pt. susp. inj. · Novartis Pharma GMBH

Sandostatin Lar 20MG VialSaudi Arabia · Sandoz

Sandostatin Lar 30MG VialSaudi Arabia · Sandoz

acetato de octreotidaBrazil · Cristália Produtos Químicos Farmacêuticos Ltda.

OctrideBrazil · Sun Farmacêutica do Brasil Ltda

SandostatinBrazil · Novartis Biociencias S.A

Octreotide Acetate OmegaCanada · 500 MCG / ML · Solution · Omega Laboratories Limited

Octreotide Acetate OmegaCanada · 50 MCG / ML · Solution · Omega Laboratories Limited

Octreotide Acetate OmegaCanada · 200 MCG / ML · Solution · Omega Laboratories Limited

OczyesaEuropean Union · Camurus AB

MycapssaEuropean Union · Amryt Pharmaceuticals DAC

OcranSaudi Arabia · GP Pharm SA

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Octreotide
Strength: 0.1 mg/ml
Dosage form: injection, solution
Route: intravenous&&subcutaneous
Register: Singapore (HSA)
Status: Authorised
Status in the register: Registered
Authorised: 28 May 2026
Registration: SIN17549P
Marketing authorisation holder: Goldplus Universal Pte LTD
Manufacturer: Farmak Joint Stock Company, UKRAINE
ATC code: H01CB02
Group: Systemic hormonal preparations
Supply: Prescription Only

Octreotide · 30 mg/vial · injection, powder, lyophilized, for suspension,extended release

Singapore

SANDOSTATIN INJECTION 0.1 mg/mlOctreotide · 0.1 mg/ml · injectionSingapore

SANDOSTATIN LAR FOR INJECTION 20 mgOctreotide · 20 mg/vial · injectionSingapore

SANDOSTATIN LAR FOR INJECTION 30 mgOctreotide · 30 mg/vial · injectionSingapore

Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vialOctreotide · 20mg/vial · injection, powder, lyophilized, for suspension,extended releaseSingapore

Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vialOctreotide · 30.0mg/vial · injection, powder, lyophilized, for suspension,extended releaseSingapore